Searched for
PHARMACEUTICALS
HNIs now own a record Rs 10 lakh crore worth of Indian stocks. Laurus Labs, Cupid among top 10 favouritesIn an impressive move, high net worth individuals (HNIs) have ramped up their investments, amassing a monumental ₹10 lakh crore in Indian e...
"Indian genius, Italian enterprise can truly complement each other": Piyush GoyalPiyush Goyal emphasized the need for increased collaboration between India and Italy in several sectors. The focus includes pharmaceuticals...
Drug regulator seeks pre-1988 approval records to compile national list of medicinesThe Indian government has initiated a process to create a consolidated list of approved drugs for regulatory purposes. This list will inclu...
India needs policy predictability to speed up drug approvals and boost pharma innovation: OPPI DGAnil Matai from the Organisation of Pharmaceutical Producers of India emphasized the need for regulatory predictability. He noted that Indi...
IPO-bound Aragen plans to spend Rs 15 billion over 3 years for expansion, MD saysAragen Life Sciences will invest approximately 15 billion rupees over three years for its expansion. This investment aims to enhance capaci...
Breckenridge Pharmaceutical recalls blood pressure medicine Propranolol: Lot number, expiration date, health risks and what you should do nowBreckenridge Pharmaceutical Propranolol recall explained: Breckenridge Pharmaceutical has recalled one lot of its 60 mg extended-release pr...
DRI searches Cipla's Mumbai office, Bhiwandi depot over imported drugsThe Directorate of Revenue Intelligence's Mumbai zonal unit has searched Cipla's office in Vikhroli and its depot in Bhiwandi over the clas...
Indian conglomerates embrace GCC model to centralise operations, drive efficiencyIndian companies are adopting the global capability centre model for improved efficiency and competitiveness. Leading business groups like ...
Glenmark launches generic of Inlyta tablets for kidney cancer treatment in USGlenmark Pharmaceuticals Inc has announced the launch of Axitinib Tablets in the United States in two strengths. These tablets are a generi...
Sun Pharma eyes $4 billion loan for Organon buy, five banks likely to anchor refinancingSun Pharmaceutical Industries is gearing up to secure a substantial $4 billion syndicated loan aimed at refining its financial structure. T...
Compulsory licensing of drugs only after exhausting all other measures: Department of Pharmaceuticals secretary Manoj JoshiThe government plans to address the high costs of innovative medicines by first negotiating prices. Compulsory licensing will be considered...
Blue Jet Healthcare evaluating Rs 500 crore investment in Andhra Pradesh API manufacturing facilityBlue Jet Healthcare is evaluating the acquisition of 50 acres of land in Andhra Pradesh for an API manufacturing facility. The company plan...
NPPA issues strict guidelines for trade margin rationalisation on 137 cancer drugs to benefit patientsThe National Pharmaceutical Pricing Authority has implemented strict monitoring of Trade Margin Rationalisation for certain anti-cancer dru...
PLI schemes achieve 76% of investment target, 64% of production goal: Niti AayogThe production-linked incentive (PLI) scheme has achieved 76% of its investment target and 64% of its production target, with electronics, ...
Lupin partner Sandoz launches RanluspecTM across Europe for retinal disease treatmentLupin Ltd has partnered with Sandoz to launch RanluspecTM, a biosimilar for Ranibizumab, across Europe. This launch will help to improve ac...
India may open doors to multinational pharma firms for first-in-human Phase I trialsIndia is considering modifications to its pharmaceutical regulatory framework to attract multinational companies for clinical trials. Discu...
Drugmakers tap China AI app boom to reach doctors as crackdown upends marketingAs scrutiny intensifies, Chinese pharmaceutical companies are shifting gears toward digital marketing initiatives. Traditional face-to-face...
Government extends ₹2,700-crore PLI scheme for medical devices till 2035-36, eases eligibility normsThe government has extended the ₹2,700-crore production-linked incentive (PLI) scheme for domestic medical device manufacturing until 2035-...
Pharma industry steps up API investments to cut import dependence, move up value chainIndia's pharmaceutical sector is shifting towards high-value medicines and reducing reliance on imports through local manufacturing. Invest...
Glenmark Pharma Q2 Results: Net profit plunges 56% to Rs 264 crore, revenue down at Rs 4,247 crGlenmark Pharmaceuticals experienced a 56.78 percent drop in consolidated profit after tax during the September quarter. Total revenue from...